Skip to main content
Top
Published in: Virology Journal 1/2009

Open Access 01-12-2009 | Methodology

A rapid and efficient method for studies of virus interaction at the host cell surface using enteroviruses and real-time PCR

Authors: Nina Jonsson, Maria Gullberg, Stina Israelsson, A Michael Lindberg

Published in: Virology Journal | Issue 1/2009

Login to get access

Abstract

Background

Measuring virus attachment to host cells is of great importance when trying to identify novel receptors. The presence of a usable receptor is a major determinant of viral host range and cell tropism. Furthermore, identification of appropriate receptors is central for the understanding of viral pathogenesis and gives possibilities to develop antiviral drugs. Attachment is presently measured using radiolabeled and subsequently gradient purified viruses. Traditional methods are expensive and time-consuming and not all viruses are stable during a purification procedure; hence there is room for improvement. Real-time PCR (RT-PCR) has become the standard method to detect and quantify virus infections, including enteroviruses, in clinical samples. For instance, primers directed to the highly conserved 5' untranslated region (5'UTR) of the enterovirus genome enable detection of a wide spectrum of enteroviruses. Here, we evaluate the capacity of the RT-PCR technology to study enterovirus host cell interactions at the cell surface and compare this novel implementation with an established assay using radiolabeled viruses.

Results

Both purified and crude viral extracts of CVB5 generated comparable results in attachment studies when analyzed with RT-PCR. In addition, receptor binding studies regarding viruses with coxsackie- and adenovirus receptor (CAR) and/or decay accelerating factor (DAF) affinity, further demonstrated the possibility to use RT-PCR to measure virus attachment to host cells. Furthermore, the RT-PCR technology and crude viral extracts was used to study attachment with low multiplicity of infection (0.05 × 10-4TCID50/cell) and low cell numbers (250), which implies the range of potential implementations of the presented technique.

Conclusion

We have implemented the well-established RT-PCR technique to measure viral attachment to host cells with high accuracy and reproducibility, at low cost and with less effort than traditional methods. Furthermore, replacing traditional methods with RT-PCR offers the opportunity to use crude virus containing extracts to investigate attachment, which could be considered as a step towards viral attachment studies in a more natural state.
Appendix
Available only for authorised users
Literature
1.
go back to reference Rossmann MG, He Y, Kuhn RJ: Picornavirus-receptor interactions. Trends Microbiol 2002, 10: 324-331. 10.1016/S0966-842X(02)02383-1CrossRefPubMed Rossmann MG, He Y, Kuhn RJ: Picornavirus-receptor interactions. Trends Microbiol 2002, 10: 324-331. 10.1016/S0966-842X(02)02383-1CrossRefPubMed
2.
go back to reference Evans DJ, Almond JW: Cell receptors for picornaviruses as determinants of cell tropism and pathogenesis. Trends Microbiol 1998, 6: 198-202. 10.1016/S0966-842X(98)01263-3CrossRefPubMed Evans DJ, Almond JW: Cell receptors for picornaviruses as determinants of cell tropism and pathogenesis. Trends Microbiol 1998, 6: 198-202. 10.1016/S0966-842X(98)01263-3CrossRefPubMed
3.
go back to reference Fauquet CM, Mayo MA, Maniloff J, Desselberger U, Bell LA: Virus Taxonomy. Elsevier Academic Press; 2005. Fauquet CM, Mayo MA, Maniloff J, Desselberger U, Bell LA: Virus Taxonomy. Elsevier Academic Press; 2005.
4.
go back to reference Pallanch MA, Roos RP: Enteroviruses: polioviruses, coxsackieviruses, ehcoviruses and newer enteroviruses. fourth edition. Philadelphia, PA: Lippincott, Williams and Wilkins; 2001. Pallanch MA, Roos RP: Enteroviruses: polioviruses, coxsackieviruses, ehcoviruses and newer enteroviruses. fourth edition. Philadelphia, PA: Lippincott, Williams and Wilkins; 2001.
5.
go back to reference Racianello VR: Picornaviridae: The viruses and their replication. 4th edition. Philadelphia: Lippincott Williams & Wilkins; 2001. Racianello VR: Picornaviridae: The viruses and their replication. 4th edition. Philadelphia: Lippincott Williams & Wilkins; 2001.
6.
go back to reference Mendelsohn CL, Wimmer E, Racaniello VR: Cellular receptor for poliovirus: molecular cloning, nucleotide sequence, and expression of a new member of the immunoglobulin superfamily. Cell 1989, 56: 855-865. 10.1016/0092-8674(89)90690-9CrossRefPubMed Mendelsohn CL, Wimmer E, Racaniello VR: Cellular receptor for poliovirus: molecular cloning, nucleotide sequence, and expression of a new member of the immunoglobulin superfamily. Cell 1989, 56: 855-865. 10.1016/0092-8674(89)90690-9CrossRefPubMed
7.
go back to reference Bergelson JM, Shepley MP, Chan BM, Hemler ME, Finberg RW: Identification of the integrin VLA-2 as a receptor for echovirus 1. Science 1992, 255: 1718-1720. 10.1126/science.1553561CrossRefPubMed Bergelson JM, Shepley MP, Chan BM, Hemler ME, Finberg RW: Identification of the integrin VLA-2 as a receptor for echovirus 1. Science 1992, 255: 1718-1720. 10.1126/science.1553561CrossRefPubMed
8.
go back to reference Bergelson JM, St John N, Kawaguchi S, Chan M, Stubdal H, Modlin J, Finberg RW: Infection by echoviruses 1 and 8 depends on the alpha 2 subunit of human VLA-2. J Virol 1993, 67: 6847-6852.PubMedCentralPubMed Bergelson JM, St John N, Kawaguchi S, Chan M, Stubdal H, Modlin J, Finberg RW: Infection by echoviruses 1 and 8 depends on the alpha 2 subunit of human VLA-2. J Virol 1993, 67: 6847-6852.PubMedCentralPubMed
9.
go back to reference Roivainen M, Piirainen L, Hovi T, Virtanen I, Riikonen T, Heino J, Hyypia T: Entry of coxsackievirus A9 into host cells: specific interactions with alpha v beta 3 integrin, the vitronectin receptor. Virology 1994, 203: 357-365. 10.1006/viro.1994.1494CrossRefPubMed Roivainen M, Piirainen L, Hovi T, Virtanen I, Riikonen T, Heino J, Hyypia T: Entry of coxsackievirus A9 into host cells: specific interactions with alpha v beta 3 integrin, the vitronectin receptor. Virology 1994, 203: 357-365. 10.1006/viro.1994.1494CrossRefPubMed
10.
go back to reference Nelsen-Salz B, Eggers HJ, Zimmermann H: Integrin alpha(v)beta3 (vitronectin receptor) is a candidate receptor for the virulent echovirus 9 strain Barty. J Gen Virol 1999,80(Pt 9):2311-2113.CrossRefPubMed Nelsen-Salz B, Eggers HJ, Zimmermann H: Integrin alpha(v)beta3 (vitronectin receptor) is a candidate receptor for the virulent echovirus 9 strain Barty. J Gen Virol 1999,80(Pt 9):2311-2113.CrossRefPubMed
11.
go back to reference Greve JM, Davis G, Meyer AM, Forte CP, Yost SC, Marlor CW, Kamarck ME, McClelland A: The major human rhinovirus receptor is ICAM-1. Cell 1989, 56: 839-847. 10.1016/0092-8674(89)90688-0CrossRefPubMed Greve JM, Davis G, Meyer AM, Forte CP, Yost SC, Marlor CW, Kamarck ME, McClelland A: The major human rhinovirus receptor is ICAM-1. Cell 1989, 56: 839-847. 10.1016/0092-8674(89)90688-0CrossRefPubMed
12.
go back to reference Staunton DE, Dustin ML, Erickson HP, Springer TA: The arrangement of the immunoglobulin-like domains of ICAM-1 and the binding sites for LFA-1 and rhinovirus. Cell 1990, 61: 243-254. 10.1016/0092-8674(90)90805-OCrossRefPubMed Staunton DE, Dustin ML, Erickson HP, Springer TA: The arrangement of the immunoglobulin-like domains of ICAM-1 and the binding sites for LFA-1 and rhinovirus. Cell 1990, 61: 243-254. 10.1016/0092-8674(90)90805-OCrossRefPubMed
13.
go back to reference Bergelson JM, Chan M, Solomon KR, St John NF, Lin H, Finberg RW: Decay-accelerating factor (CD55), a glycosylphosphatidylinositol-anchored complement regulatory protein, is a receptor for several echoviruses. Proc Natl Acad Sci USA 1994, 91: 6245-6248. 10.1073/pnas.91.13.6245PubMedCentralCrossRefPubMed Bergelson JM, Chan M, Solomon KR, St John NF, Lin H, Finberg RW: Decay-accelerating factor (CD55), a glycosylphosphatidylinositol-anchored complement regulatory protein, is a receptor for several echoviruses. Proc Natl Acad Sci USA 1994, 91: 6245-6248. 10.1073/pnas.91.13.6245PubMedCentralCrossRefPubMed
14.
go back to reference Ward T, Pipkin PA, Clarkson NA, Stone DM, Minor PD, Almond JW: Decay-accelerating factor CD55 is identified as the receptor for echovirus 7 using CELICS, a rapid immuno-focal cloning method. Embo J 1994, 13: 5070-5074.PubMedCentralPubMed Ward T, Pipkin PA, Clarkson NA, Stone DM, Minor PD, Almond JW: Decay-accelerating factor CD55 is identified as the receptor for echovirus 7 using CELICS, a rapid immuno-focal cloning method. Embo J 1994, 13: 5070-5074.PubMedCentralPubMed
15.
go back to reference Bergelson JM, Cunningham JA, Droguett G, Kurt-Jones EA, Krithivas A, Hong JS, Horwitz MS, Crowell RL, Finberg RW: Isolation of a common receptor for Coxsackie B viruses and adenoviruses 2 and 5. Science 1997, 275: 1320-1323. 10.1126/science.275.5304.1320CrossRefPubMed Bergelson JM, Cunningham JA, Droguett G, Kurt-Jones EA, Krithivas A, Hong JS, Horwitz MS, Crowell RL, Finberg RW: Isolation of a common receptor for Coxsackie B viruses and adenoviruses 2 and 5. Science 1997, 275: 1320-1323. 10.1126/science.275.5304.1320CrossRefPubMed
16.
go back to reference Tomko RP, Xu R, Philipson L: HCAR and MCAR: the human and mouse cellular receptors for subgroup C adenoviruses and group B coxsackieviruses. Proc Natl Acad Sci USA 1997, 94: 3352-3356. 10.1073/pnas.94.7.3352PubMedCentralCrossRefPubMed Tomko RP, Xu R, Philipson L: HCAR and MCAR: the human and mouse cellular receptors for subgroup C adenoviruses and group B coxsackieviruses. Proc Natl Acad Sci USA 1997, 94: 3352-3356. 10.1073/pnas.94.7.3352PubMedCentralCrossRefPubMed
17.
go back to reference Roelvink PW, Lizonova A, Lee JG, Li Y, Bergelson JM, Finberg RW, Brough DE, Kovesdi I, Wickham TJ: The coxsackievirus-adenovirus receptor protein can function as a cellular attachment protein for adenovirus serotypes from subgroups A, C, D, E, and F. J Virol 1998, 72: 7909-7915.PubMedCentralPubMed Roelvink PW, Lizonova A, Lee JG, Li Y, Bergelson JM, Finberg RW, Brough DE, Kovesdi I, Wickham TJ: The coxsackievirus-adenovirus receptor protein can function as a cellular attachment protein for adenovirus serotypes from subgroups A, C, D, E, and F. J Virol 1998, 72: 7909-7915.PubMedCentralPubMed
18.
go back to reference Nicholson-Weller A: Decay accelerating factor (CD55). Curr Top Microbiol Immunol 1992, 178: 7-30.PubMed Nicholson-Weller A: Decay accelerating factor (CD55). Curr Top Microbiol Immunol 1992, 178: 7-30.PubMed
19.
go back to reference Bergelson JM, Mohanty JG, Crowell RL, St John NF, Lublin DM, Finberg RW: Coxsackievirus B3 adapted to growth in RD cells binds to decay-accelerating factor (CD55). J Virol 1995, 69: 1903-1916.PubMedCentralPubMed Bergelson JM, Mohanty JG, Crowell RL, St John NF, Lublin DM, Finberg RW: Coxsackievirus B3 adapted to growth in RD cells binds to decay-accelerating factor (CD55). J Virol 1995, 69: 1903-1916.PubMedCentralPubMed
20.
go back to reference Shafren DR, Bates RC, Agrez MV, Herd RL, Burns GF, Barry RD: Coxsackieviruses B1, B3, and B5 use decay accelerating factor as a receptor for cell attachment. J Virol 1995, 69: 3873-3877.PubMedCentralPubMed Shafren DR, Bates RC, Agrez MV, Herd RL, Burns GF, Barry RD: Coxsackieviruses B1, B3, and B5 use decay accelerating factor as a receptor for cell attachment. J Virol 1995, 69: 3873-3877.PubMedCentralPubMed
21.
22.
go back to reference Powell RM, Schmitt V, Ward T, Goodfellow I, Evans DJ, Almond JW: Characterization of echoviruses that bind decay accelerating factor (CD55): evidence that some haemagglutinating strains use more than one cellular receptor. J Gen Virol 1998,79(Pt 7):1707-1713.CrossRefPubMed Powell RM, Schmitt V, Ward T, Goodfellow I, Evans DJ, Almond JW: Characterization of echoviruses that bind decay accelerating factor (CD55): evidence that some haemagglutinating strains use more than one cellular receptor. J Gen Virol 1998,79(Pt 7):1707-1713.CrossRefPubMed
23.
go back to reference Bergelson JM, Modlin JF, Wieland-Alter W, Cunningham JA, Crowell RL, Finberg RW: Clinical coxsackievirus B isolates differ from laboratory strains in their interaction with two cell surface receptors. J Infect Dis 1997, 175: 697-700.CrossRefPubMed Bergelson JM, Modlin JF, Wieland-Alter W, Cunningham JA, Crowell RL, Finberg RW: Clinical coxsackievirus B isolates differ from laboratory strains in their interaction with two cell surface receptors. J Infect Dis 1997, 175: 697-700.CrossRefPubMed
24.
go back to reference Karnauchow TM, Dawe S, Lublin DM, Dimock K: Short consensus repeat domain 1 of decay-accelerating factor is required for enterovirus 70 binding. J Virol 1998, 72: 9380-9383.PubMedCentralPubMed Karnauchow TM, Dawe S, Lublin DM, Dimock K: Short consensus repeat domain 1 of decay-accelerating factor is required for enterovirus 70 binding. J Virol 1998, 72: 9380-9383.PubMedCentralPubMed
25.
go back to reference Philipson L, Bengtsson S, Brishammar S, Svennerholm L, Zetterqvist O: Purification And Chemical Analysis Of The Erythrocyte Receptor For Hemagglutinating Enteroviruses. Virology 1964, 22: 580-590. 10.1016/0042-6822(64)90080-7CrossRefPubMed Philipson L, Bengtsson S, Brishammar S, Svennerholm L, Zetterqvist O: Purification And Chemical Analysis Of The Erythrocyte Receptor For Hemagglutinating Enteroviruses. Virology 1964, 22: 580-590. 10.1016/0042-6822(64)90080-7CrossRefPubMed
26.
go back to reference Verstrepen WA, Bruynseels P, Mertens AH: Evaluation of a rapid real-time RT-PCR assay for detection of enterovirus RNA in cerebrospinal fluid specimens. J Clin Virol 2002,25(Suppl 1):S39-43. 10.1016/S1386-6532(02)00032-XCrossRefPubMed Verstrepen WA, Bruynseels P, Mertens AH: Evaluation of a rapid real-time RT-PCR assay for detection of enterovirus RNA in cerebrospinal fluid specimens. J Clin Virol 2002,25(Suppl 1):S39-43. 10.1016/S1386-6532(02)00032-XCrossRefPubMed
27.
go back to reference Verstrepen WA, Kuhn S, Kockx MM, Vyvere ME, Mertens AH: Rapid detection of enterovirus RNA in cerebrospinal fluid specimens with a novel single-tube real-time reverse transcription-PCR assay. J Clin Microbiol 2001, 39: 4093-4096. 10.1128/JCM.39.11.4093-4096.2001PubMedCentralCrossRefPubMed Verstrepen WA, Kuhn S, Kockx MM, Vyvere ME, Mertens AH: Rapid detection of enterovirus RNA in cerebrospinal fluid specimens with a novel single-tube real-time reverse transcription-PCR assay. J Clin Microbiol 2001, 39: 4093-4096. 10.1128/JCM.39.11.4093-4096.2001PubMedCentralCrossRefPubMed
28.
go back to reference Mohamed N, Elfaitouri A, Fohlman J, Friman G, Blomberg J: A sensitive and quantitative single-tube real-time reverse transcriptase-PCR for detection of enteroviral RNA. J Clin Virol 2004, 30: 150-156. 10.1016/j.jcv.2003.08.016CrossRefPubMed Mohamed N, Elfaitouri A, Fohlman J, Friman G, Blomberg J: A sensitive and quantitative single-tube real-time reverse transcriptase-PCR for detection of enteroviral RNA. J Clin Virol 2004, 30: 150-156. 10.1016/j.jcv.2003.08.016CrossRefPubMed
29.
go back to reference Dierssen U, Rehren F, Henke-Gendo C, Harste G, Heim A: Rapid routine detection of enterovirus RNA in cerebrospinal fluid by a one-step real-time RT-PCR assay. J Clin Virol 2008, 42: 58-64. 10.1016/j.jcv.2007.11.016CrossRefPubMed Dierssen U, Rehren F, Henke-Gendo C, Harste G, Heim A: Rapid routine detection of enterovirus RNA in cerebrospinal fluid by a one-step real-time RT-PCR assay. J Clin Virol 2008, 42: 58-64. 10.1016/j.jcv.2007.11.016CrossRefPubMed
30.
go back to reference Selinka HC, Wolde A, Pasch A, Klingel K, Schnorr JJ, Kupper JH, Lindberg AM, Kandolf R: Comparative analysis of two coxsackievirus B3 strains: putative influence of virus-receptor interactions on pathogenesis. J Med Virol 2002, 67: 224-233. 10.1002/jmv.2211CrossRefPubMed Selinka HC, Wolde A, Pasch A, Klingel K, Schnorr JJ, Kupper JH, Lindberg AM, Kandolf R: Comparative analysis of two coxsackievirus B3 strains: putative influence of virus-receptor interactions on pathogenesis. J Med Virol 2002, 67: 224-233. 10.1002/jmv.2211CrossRefPubMed
31.
go back to reference Pasch A, Kupper JH, Wolde A, Kandolf R, Selinka HC: Comparative analysis of virus-host cell interactions of haemagglutinating and non-haemagglutinating strains of coxsackievirus B3. J Gen Virol 1999,80(Pt 12):3153-3158.CrossRefPubMed Pasch A, Kupper JH, Wolde A, Kandolf R, Selinka HC: Comparative analysis of virus-host cell interactions of haemagglutinating and non-haemagglutinating strains of coxsackievirus B3. J Gen Virol 1999,80(Pt 12):3153-3158.CrossRefPubMed
32.
go back to reference Arnberg N, Edlund K, Kidd AH, Wadell G: Adenovirus type 37 uses sialic acid as a cellular receptor. J Virol 2000, 74: 42-48. 10.1128/JVI.74.1.42-48.2000PubMedCentralCrossRefPubMed Arnberg N, Edlund K, Kidd AH, Wadell G: Adenovirus type 37 uses sialic acid as a cellular receptor. J Virol 2000, 74: 42-48. 10.1128/JVI.74.1.42-48.2000PubMedCentralCrossRefPubMed
33.
go back to reference Jonsson N, Gullberg M, Lindberg AM: Real-time polymerase chain reaction as a rapid and efficient alternative to estimation of picornavirus titers by tissue culture infectious dose 50% or plaque forming units. Microbiol Immunol 2009, 53: 149-154. 10.1111/j.1348-0421.2009.00107.xCrossRefPubMed Jonsson N, Gullberg M, Lindberg AM: Real-time polymerase chain reaction as a rapid and efficient alternative to estimation of picornavirus titers by tissue culture infectious dose 50% or plaque forming units. Microbiol Immunol 2009, 53: 149-154. 10.1111/j.1348-0421.2009.00107.xCrossRefPubMed
34.
go back to reference Hsu KH, Lonberg-Holm K, Alstein B, Crowell RL: A monoclonal antibody specific for the cellular receptor for the group B coxsackieviruses. J Virol 1988, 62: 1647-1652.PubMedCentralPubMed Hsu KH, Lonberg-Holm K, Alstein B, Crowell RL: A monoclonal antibody specific for the cellular receptor for the group B coxsackieviruses. J Virol 1988, 62: 1647-1652.PubMedCentralPubMed
35.
go back to reference Martino TA, Petric M, Weingartl H, Bergelson JM, Opavsky MA, Richardson CD, Modlin JF, Finberg RW, Kain KC, Willis N, et al.: The coxsackie-adenovirus receptor (CAR) is used by reference strains and clinical isolates representing all six serotypes of coxsackievirus group B and by swine vesicular disease virus. Virology 2000, 271: 99-108. 10.1006/viro.2000.0324CrossRefPubMed Martino TA, Petric M, Weingartl H, Bergelson JM, Opavsky MA, Richardson CD, Modlin JF, Finberg RW, Kain KC, Willis N, et al.: The coxsackie-adenovirus receptor (CAR) is used by reference strains and clinical isolates representing all six serotypes of coxsackievirus group B and by swine vesicular disease virus. Virology 2000, 271: 99-108. 10.1006/viro.2000.0324CrossRefPubMed
36.
go back to reference Newcombe NG, Andersson P, Johansson ES, Au GG, Lindberg AM, Barry RD, Shafren DR: Cellular receptor interactions of C-cluster human group A coxsackieviruses. J Gen Virol 2003, 84: 3041-3050. 10.1099/vir.0.19329-0CrossRefPubMed Newcombe NG, Andersson P, Johansson ES, Au GG, Lindberg AM, Barry RD, Shafren DR: Cellular receptor interactions of C-cluster human group A coxsackieviruses. J Gen Virol 2003, 84: 3041-3050. 10.1099/vir.0.19329-0CrossRefPubMed
37.
go back to reference Spiller OB, Goodfellow IG, Evans DJ, Almond JW, Morgan BP: Echoviruses and coxsackie B viruses that use human decay-accelerating factor (DAF) as a receptor do not bind the rodent analogues of DAF. J Infect Dis 2000, 181: 340-343. 10.1086/315210CrossRefPubMed Spiller OB, Goodfellow IG, Evans DJ, Almond JW, Morgan BP: Echoviruses and coxsackie B viruses that use human decay-accelerating factor (DAF) as a receptor do not bind the rodent analogues of DAF. J Infect Dis 2000, 181: 340-343. 10.1086/315210CrossRefPubMed
38.
go back to reference Goodfellow IG, Evans DJ, Blom AM, Kerrigan D, Miners JS, Morgan BP, Spiller OB: Inhibition of coxsackie B virus infection by soluble forms of its receptors: binding affinities, altered particle formation, and competition with cellular receptors. J Virol 2005, 79: 12016-12024. 10.1128/JVI.79.18.12016-12024.2005PubMedCentralCrossRefPubMed Goodfellow IG, Evans DJ, Blom AM, Kerrigan D, Miners JS, Morgan BP, Spiller OB: Inhibition of coxsackie B virus infection by soluble forms of its receptors: binding affinities, altered particle formation, and competition with cellular receptors. J Virol 2005, 79: 12016-12024. 10.1128/JVI.79.18.12016-12024.2005PubMedCentralCrossRefPubMed
39.
go back to reference Crowell RL: Comparative generic charactericstics of picornavirus-receptor interactions. New York: Raven Press; 1976. Crowell RL: Comparative generic charactericstics of picornavirus-receptor interactions. New York: Raven Press; 1976.
40.
go back to reference Polacek C, Ekstrom JO, Lundgren A, Lindberg AM: Cytolytic replication of coxsackievirus B2 in CAR-deficient rhabdomyosarcoma cells. Virus Res 2005, 113: 107-115. 10.1016/j.virusres.2005.04.021CrossRefPubMed Polacek C, Ekstrom JO, Lundgren A, Lindberg AM: Cytolytic replication of coxsackievirus B2 in CAR-deficient rhabdomyosarcoma cells. Virus Res 2005, 113: 107-115. 10.1016/j.virusres.2005.04.021CrossRefPubMed
41.
go back to reference Milstone AM, Petrella J, Sanchez MD, Mahmud M, Whitbeck JC, Bergelson JM: Interaction with coxsackievirus and adenovirus receptor, but not with decay-accelerating factor (DAF), induces A-particle formation in a DAF-binding coxsackievirus B3 isolate. J Virol 2005, 79: 655-660. 10.1128/JVI.79.1.655-660.2005PubMedCentralCrossRefPubMed Milstone AM, Petrella J, Sanchez MD, Mahmud M, Whitbeck JC, Bergelson JM: Interaction with coxsackievirus and adenovirus receptor, but not with decay-accelerating factor (DAF), induces A-particle formation in a DAF-binding coxsackievirus B3 isolate. J Virol 2005, 79: 655-660. 10.1128/JVI.79.1.655-660.2005PubMedCentralCrossRefPubMed
Metadata
Title
A rapid and efficient method for studies of virus interaction at the host cell surface using enteroviruses and real-time PCR
Authors
Nina Jonsson
Maria Gullberg
Stina Israelsson
A Michael Lindberg
Publication date
01-12-2009
Publisher
BioMed Central
Published in
Virology Journal / Issue 1/2009
Electronic ISSN: 1743-422X
DOI
https://doi.org/10.1186/1743-422X-6-217

Other articles of this Issue 1/2009

Virology Journal 1/2009 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.